R&D
Partner Content
Novo Nordisk seeks to target heart disease with Cardior acqu...
Cardior CSO will speak at the Oligonucleotide Therapeutics and Delivery conference following announcement of a buyout by Novo Nordisk to enhance their
R&D
Partner Content
6th Inflammasome Therapeutics Summit
In the rapidly evolving field of inflammasome therapeutics, the need for innovative approaches to overcome the preclinical and clinical hurdles is more critical than ever.
R&D
Partner Content
2nd Covalent Drug Discovery & Development Summit
Discover & Develop Selective, Clinically Validated & Novel Covalent Therapeutics to Expand the Targetable Proteome & Non-Cystine Amino Acid Space in Oncology, Immunology & B
R&D
Partner Content
7th TPD & Induced Proximity Summit
Fast-Track Discovery, Development & Approval of Selective, Safe & Clinically Relevant TACs & Glues for Degradation, Stabilization, & Phosphorylation to Successfully Address
R&D
Partner Content
5th Gene Therapy Immunogenicity Summit
Optimise Safety & De-Risk Efficacy of Viral Vector Based Gene Therapies
